Diabetes a obezita - Issue 41/2021

3
Diabetologie – obor spolupráce českých a slovenských zdravotníků

7
The potential of induced pluripotent stem cells in the study and treatment of monogenic diabetes

Terézia Valkovičová, Martina Škopková, Ying Cai, Juraj Staník, Miriam Cnop, Daniela Gašperíková

16
Discordance between blood glucose and HbA1c – is an explanation possible according to the biokinetic model of glycation?

Oliver Rácz, Peter Dombrovský, Vladimír Heriban, Marek Brenišin, Katarína Muriová

23
News in the field of 2nd generation of basal insulin analogs in type 1 diabetes and data from continuous glucose monitoring

Peter Novodvorský

29
Specifics of choosing antidiabetic treatment for elderly patients with type 2 diabetes mellitus

Zbynek Schroner, Vladimír Uličiansky


35
Studies with SGLT2 inhibitors primarily focused on renal parameters in patients with chronic kidney disease with/without type 2 diabetes mellitus

Zbynek Schroner


49
A improving adherence to treatment – metformin XR
51
What new antidiabetic drugs can do in present clinical practice

Ján Murín

56
Today we can influence overweight and obesity – and thus prevent their consequences, as is the development of diabetes or cardiovascular disease
60
Education of diabetic patients during the COVID-19 pandemic

Andrea Bukovská


39
What helps us in deciding on antidiabetic treatment for individual patients – case reports from routine clinical practice

Zuzana Ondreičková, Martina Gubíková, Zbynek Schroner

44
Familial chylomicronemia – pathogenesis, clinical manifestations and a case report

Katarína Rašlová, Alexander Klabník, Miroslava Hučková, Daniela Gašperíková, Anna Maňková, Michal Vrablík, Richard Češka, Daniela Balažiová


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account